Northcape Wealth Management LLC purchased a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent filing with the SEC. The fund purchased 8,353 shares of the company’s stock, valued at approximately $1,073,000.
Several other hedge funds have also bought and sold shares of MKGAF. Addison Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at about $90,000. Comprehensive Financial Planning Inc. PA bought a new stake in shares of Merck KGaA in the second quarter worth about $134,000. Stevens Capital Partners bought a new stake in shares of Merck KGaA in the second quarter worth about $220,000. United Bank purchased a new stake in shares of Merck KGaA in the second quarter worth about $248,000. Finally, CM Wealth Advisors LLC purchased a new stake in shares of Merck KGaA in the second quarter worth about $334,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of Merck KGaA stock opened at $167.38 on Thursday. The firm has a market cap of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96. The stock has a 50 day moving average of $162.50 and a 200 day moving average of $148.28. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
